These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4257083)

  • 21. [Diversity of kinin-forming enzymes of human plasma].
    Hojima Y; Moriya H; Moriwaki C
    Arerugi; 1970 Nov; 19(11):824-30. PubMed ID: 5530777
    [No Abstract]   [Full Text] [Related]  

  • 22. Relation of the fibrinolytic mechanism to other proteolytic systems in plasma.
    Eisen V
    Proc R Soc Lond B Biol Sci; 1969 Jul; 173(1032):407-10. PubMed ID: 4389514
    [No Abstract]   [Full Text] [Related]  

  • 23. Conversion of Hageman factor (factor XII) of the guinea pig to prekallikrein activator and inhibition of the formed kallikrein by a natural plasma inhibitor.
    Takeuchi Y; Movat HZ
    Eur J Immunol; 1972 Aug; 2(4):345-9. PubMed ID: 4538864
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative study of proactivators of the fibrinolysin system in three mammalian species.
    Takada Y; Takada A; Ambrus JL
    Thromb Diath Haemorrh; 1969 Jun; 21(3):594-603. PubMed ID: 4240872
    [No Abstract]   [Full Text] [Related]  

  • 25. Significance of direct and indirect kinin formation by plasmin in human plasma.
    Seidel G; Stücker HU; Vogt W
    Biochem Pharmacol; 1971 Aug; 20(8):1859-66. PubMed ID: 4257799
    [No Abstract]   [Full Text] [Related]  

  • 26. Interaction of human plasminogen with deoxyribonucleic acids. II. Protection of human plasminogen against catalytic activation with deoxyribonucleic acids.
    Hakim AA
    Enzymologia; 1970 Jan; 38(1):57-81. PubMed ID: 4244649
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of modified streptokinase as the activator of bovine and human plasminogen.
    Taylor FB; Beisswenger JG
    J Biol Chem; 1973 Feb; 248(4):1127-34. PubMed ID: 4265642
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biochemistry of the kallikrein-kinin system].
    Kato H; Fujii S
    Nihon Rinsho; 1978 Aug; 36(8):2865-72. PubMed ID: 152362
    [No Abstract]   [Full Text] [Related]  

  • 29. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
    Kaplan AP; Meier HL; Mandle R
    Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction of streptokinase and human plasminogen. VI. Function of the streptokinase moiety in the activator complex.
    Buck FF; Boggiano E
    J Biol Chem; 1971 Apr; 246(7):2091-6. PubMed ID: 4252219
    [No Abstract]   [Full Text] [Related]  

  • 31. Isoelectric focusing of human plasminogen, plasmin, and derived heavy (A) and light (B) chains.
    Robbins KC; Summaria L
    Ann N Y Acad Sci; 1973 Jun; 209():397-404. PubMed ID: 4268482
    [No Abstract]   [Full Text] [Related]  

  • 32. The kinin-system of human plasma. I. Isolation of a low molecular weight activator of prekallikrein.
    Movat HZ; Poon MC; Takeuchi Y
    Int Arch Allergy Appl Immunol; 1971; 40(1):89-112. PubMed ID: 5313313
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [ON A METHOD FOR THE DETERMINATION OF PLASMA FIBRINOLYTIC ACTIVITY].
    SHIRAI T
    Klin Wochenschr; 1964 Jun; 42():586-8. PubMed ID: 14236987
    [No Abstract]   [Full Text] [Related]  

  • 36. Problems in evaluating the components of the kinin system.
    Hamberg U
    Ann Chir Gynaecol Fenn; 1972; 61(5):238-50. PubMed ID: 4265521
    [No Abstract]   [Full Text] [Related]  

  • 37. Streptokinase-activatable proactivator of human and bovine plasminogen.
    Takada A; Takada Y; Ambrus JL
    J Biol Chem; 1970 Dec; 245(23):6389-96. PubMed ID: 4991888
    [No Abstract]   [Full Text] [Related]  

  • 38. Soluble mediators of injury of the microvasculature; Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems.
    Cochrane CG; Revak SD; Wuepper KD; Johnston A; Morrison DC; Ulevitch R
    Microvasc Res; 1974 Jul; 8(1):112-21. PubMed ID: 4278273
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum.
    NORMAN PS
    J Exp Med; 1957 Sep; 106(3):423-37. PubMed ID: 13463252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the NH 2 -terminal glutamic acid and NH 2 -terminal lysine forms of human plasminogen isolated by affinity chromatography and isoelectric focusing methods.
    Summaria L; Arzadon L; Bernabe P; Robins KC
    J Biol Chem; 1973 May; 248(9):2984-91. PubMed ID: 4700448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.